v3.26.1
Stock Option Plan (Tables)
 3 Months Ended 12 Months Ended
Mar. 31, 2026
Dec. 31, 2025
Stock Option Plan [Abstract]    
Schedule of Stock Option Activity

Stock option activity during the three months ended March 31, 2026 was as follows:

 

    Number of
options		     Weighted
average
exercise
price		     Weighted
average
remaining
contractual
life
(years)		     Aggregate
intrinsic
value		  
Balance as of December 31, 2025     14,162,648     $ 0.31       6.41     $ 2,541  
Options granted     135,000       1.09                  
Options exercised     (639,738 )     0.16               598  
Options cancelled     (154,320 )     0.32                  
Balance as of March 31, 2026     13,503,590     $ 0.33       6.33     $ 10,322  
Vested and expected to vest at March 31, 2026     13,503,590     $ 0.33       6.33     $ 10,322  
Exercisable at March 31, 2026     9,433,058     $ 0.27       5.25     $ 7,765  

Activity under the 2016 Plan and 2010 Plan consists of the following:

 

    Number of
options		     Weighted
average
exercise
price		     Weighted
average
remaining
contractual
life (years)		     Aggregate
intrinsic
value		  
Balance as of December 31, 2023     10,589,851     $ 0.22       6.50     $ 954  
Options granted     2,935,275       0.31                  
Options exercised     (266,799 )     0.18               36  
Options cancelled     (484,739 )     0.25                  
Balance as of December 31, 2024     12,773,588       0.24       6.31       3,186  
Options granted     4,039,029       0.49                  
Options exercised     (624,451 )     0.21               176  
Options cancelled     (2,025,518 )     0.26                  
Balance as of December 31, 2025     14,162,648       0.31       6.41       2,541  
Vested and expected to vest at December 31, 2025     14,162,648       0.31       6.41       2,541  
Exercisable at December 31, 2025     9,370,813     $ 0.25       5.11     $ 2,290  
Schedule of Fair Value of Stock Options Granted

The fair value of stock options granted was estimated using the following weighted-average assumptions:

 

    Three months ended
March 31,		  
    2026     2025  
Expected term (in years)     6.1       5.7  
Expected volatility     64.9 %     65.4 %
Risk-free rate     3.9 %     4.1 %
Dividend yield     —       —  

The fair value of stock options granted was estimated using the following weighted-average assumptions:

 

    2025     2024  
Expected term (in years)     5.9       5.7  
Expected volatility     65.0 %     64.7 %
Risk-free rate     4.1 %     4.0 %
Dividend yield     —       —  
Schedule of Stock-Based Compensation

The Company’s total stock-based compensation was as follows:

 

    Three Months Ended
March 31,		  
    2026     2025  
Cost of revenue   $ 18     $ 3  
Research and development     11       11  
Selling, general and administrative     96       169  
Total stock-based compensation   $ 125     $ 183  

The Company’s total stock-based compensation was as follows:

 

    2025     2024  
Cost of revenue   $ 13     $ 14  
Research and development     57       59  
Selling, general and administrative     483       440  
Total stock-based compensation   $ 553     $ 513